PubMed:33430924 / 2449-2602 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/33430924","sourcedb":"PubMed","sourceid":"33430924","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/33430924","text":"Re-assessment of the sample size needed for the confirmatory part 2 and confirmation of the effect of BIO101 observed in part 1 in the target population.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T18","span":{"begin":0,"end":153},"obj":"Sentence"},{"id":"T18","span":{"begin":0,"end":153},"obj":"Sentence"}],"attributes":[{"subj":"T18","pred":"source","obj":"Inflammaging"},{"subj":"T18","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#9493ec","default":true}]}]}}